Announcements Trials
Browse Landscape

Phase

Phase NA 16Phase 2 4Phase 1/2 2Phase 3 1Phase 1 1

Status

Recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 1Colorectal Neoplasms 1Barrett Esophagus 1Adenomatous Polyposis Coli 1Adenocarcinoma of the Esophagogastric Junction 1Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 780Fluorouracil 638Capecitabine 575Gemcitabine 478Leucovorin 459Bevacizumab 445Irinotecan 444Cisplatin 338Radiotherapy 283Cetuximab 252Paclitaxel 180S 1 (combination) 176pembrolizumab 173Docetaxel 156Drug Therapy 147Nivolumab 146sintilimab 143tislelizumab 131apatinib 131130-nm albumin-bound paclitaxel 128Folfox protocol 121durvalumab 119Albumin-Bound Paclitaxel 117camrelizumab 107lenvatinib 106Panitumumab 106regorafenib 102Surgical Procedures, Operative 102Sorafenib 99Radiation 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Endoscopy, Digestive System × Gastrointestinal × Clear all
NCT04939051 2026-05-13

Obeticholic Acid for Prevention in Barrett's Esophagus

National Cancer Institute (NCI)

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT06557733 2026-05-13

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Recruiting
38 enrolled
Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT06782048 2025-01-17

Use of Pyrvinium to Reverse Stomach Precancerous Conditions

National University Hospital, Singapore

Phase 2 Not yet recruiting
50 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02287129 2023-11-28

MEMORI

Technical University of Munich

Phase 2 Completed
75 enrolled
Gastrointestinal

Adenocarcinoma of the Esophagogastric Junction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡